Tech Company Financing Transactions
Vista Therapeutics Funding Round
TEL Venture Capital participated in a $1 million venture round for Vista Therapeutics. The round was announced on 3/31/2009.
Transaction Overview
Company Name
Announced On
3/31/2009
Transaction Type
Venture Equity
Amount
$1,026,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3900 Paseo del Sol
Santa Fe, NM 87507
USA
Santa Fe, NM 87507
USA
Phone
Website
Email Address
Overview
The company develops and markets nanowire-based biosensors. Nanotechnology will profoundly affect multiple facets of drug discovery, drug safety assessment and the diagnosis and treatment of disease. The most important near-term contribution of nanotechnology to biomedicine will be in the form of extremely sensitive biosensors.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Spencer Farr
Founder
Charles Lieber
Browse more venture capital transactions:
Prev: 3/31/2009: Clustrix venture capital transaction
Next: 3/31/2009: ReImage venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs